Long-term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52-week postmarketing clinical study (TWINKLE).
- DOI
- 10.1111/jdi.70135
- Published
- 2025 Oct
- Container
- Journal of diabetes investigation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/jdi.70135,
title = {Long-term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52-week postmarketing clinical study (TWINKLE).},
author = {Babazono T and Osonoi T and Okamoto H and Onishi Y and Nakamoto S and Kashima M and Kawanami D and Nakashima E and Watabe K and Nunami N and Hagi K},
year = {2025},
journal = {Journal of diabetes investigation},
doi = {10.1111/jdi.70135},
url = {https://doi.org/10.1111/jdi.70135}
}RIS
TY - JOUR TI - Long-term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52-week postmarketing clinical study (TWINKLE). AU - Babazono T AU - Osonoi T AU - Okamoto H AU - Onishi Y AU - Nakamoto S AU - Kashima M AU - Kawanami D AU - Nakashima E AU - Watabe K AU - Nunami N AU - Hagi K PY - 2025 JO - Journal of diabetes investigation DO - 10.1111/jdi.70135 UR - https://doi.org/10.1111/jdi.70135 ER -
APA
T, B., T, O., H, O., Y, O., S, N., M, K., D, K., E, N., K, W., N, N., & K, H. (2025). Long-term safety and efficacy of imeglimin in Japanese individuals with type 2 diabetes and chronic kidney disease: A 52-week postmarketing clinical study (TWINKLE).. Journal of diabetes investigation. https://doi.org/10.1111/jdi.70135
Source records
- pubmed · retrieved 2026-09-26T08:10:36.445Z